SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-016896
Filing Date
2021-07-15
Accepted
2021-07-15 08:55:29
Documents
8
Period of Report
2021-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 67392
2 ex3-1.htm EX-3.1 138360
3 ex4-1.htm EX-4.1 116188
4 ex5-1.htm EX-5.1 15966
5 ex10-1.htm EX-10.1 292389
6 ex10-2.htm EX-10.2 183255
7 ex99-1.htm EX-99.1 16952
8 ex5-1_001.jpg GRAPHIC 1902
  Complete submission text file 0001493152-21-016896.txt   834655
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 211091789
SIC: 2836 Biological Products, (No Diagnostic Substances)